Wells Fargo lowered AbbVie (NYSE:ABBV) price target from $200 to $195

By / / Abbvie, Wells Fargo

Wells Fargo analyst Mohit Bansal maintains AbbVie (NYSE:ABBV) with a Overweight and lowers the price target from $200 to $195.

Scroll to Top